Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Bald men are often viewed more negatively and as older than they really are.

A gene called HDAC9 might be a new factor in male-pattern baldness.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

Finasteride significantly improves hair growth but may cause sexual side effects.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Different processes create patterns in skin and things like hair and feathers.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

DSC cell injections significantly improved hair density and diameter, showing potential as a hair loss treatment.

Cat color patterns are determined early in development by gene expression and epidermal changes, with the Dickkopf 4 gene playing a crucial role.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Hair regrowth doesn't convert thin hairs to thick hairs, but increases overall hair density.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

UV light does not significantly affect minoxidil's ability to treat male pattern baldness.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

Finasteride works for hair loss by maintaining existing hair follicles, not reversing miniaturization.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Androgens contribute to common male hair loss; more research needed for hair growth medication.